This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frederick L. Ferris III, MD; Robert P. Murphy, MD

Arch Ophthalmol. 1996;114(12):1506-1507.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS DR BRESSLER and his colleagues¹ point out, much is yet to be learned about the prognosis of patients with age-related macular degeneration who have poorly demarcated or "occult" choroidal neovascularization (CNV). Their 2-year follow-up of 100 patients with this condition provides new and important information about the natural history of the disease. Although previous publications have suggested a more benign prognosis for these patients than for those with "classic" CNV,^2-4 patients in this study had a higher rate of visual loss than previously suspected. For patients meeting this study's eligibility criteria, the 1-year risk of losing 6 lines of visual acuity (a quadrupling of the initial visual angle) was about 40% for treated or untreated eyes. This is about the same rate of loss of visual acuity that was documented by the Macular Photocoagulation Study (MPS) Group in untreated eyes with newly developed subfoveal CNV.⁵ More . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md; Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?